Anlon Healthcare Limited IPO
Anlon Healthcare Limited was a mainboard IPO in the Pharmaceuticals sector, offered at ₹8.6–₹9.1 per share to raise ₹121 crore. The issue was subscribed 7.13× overall (QIBs 1.07×, NIIs 10.61×, retail 47.3×). It listed on 3 Sep 2025 at ₹9 and closed its first day at ₹9, a listing gain of +0.8% versus the ₹9.1 issue price. It now trades around ₹26 (+184.5% versus the issue price).
Frequently asked questions
- How many times was the Anlon Healthcare Limited IPO subscribed?
- The Anlon Healthcare Limited IPO was subscribed 7.13× overall — 1.07× in the QIB category, 10.61× among non-institutional investors, 47.3× in retail.
- What were the Anlon Healthcare Limited IPO listing gains?
- Anlon Healthcare Limited listed on 3 Sep 2025 at ₹9, closing its first day at ₹9 — a listing gain of +0.8% versus the ₹9.1 issue price.
- What were the retail allotment odds for the Anlon Healthcare Limited IPO?
- Retail was subscribed 47.3×, so a single-lot application had roughly a 2.1% chance of allotment (about 1 in 47), and allotment was finalised on 1 Sep 2025.
- What was the price band and lot size of the Anlon Healthcare Limited IPO?
- The price band was ₹8.6–₹9.1 per share, with a minimum lot of 164 shares (₹1,492 at the upper band).
- Who were the registrar and lead manager for the Anlon Healthcare Limited IPO?
- KFin Technologies Limited was the registrar, and Interactive was the book-running lead manager.